 Jason Weinman
Concepts (211)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 29 | 2025 | 2754 | 3.510 |
Why?
| | Radiation Dosage | 7 | 2025 | 193 | 2.280 |
Why?
| | Phantoms, Imaging | 3 | 2025 | 158 | 1.610 |
Why?
| | Lung Diseases, Interstitial | 9 | 2024 | 660 | 1.470 |
Why?
| | Lung Diseases | 5 | 2025 | 781 | 1.300 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 19 | 1.010 |
Why?
| | Hypertension, Pulmonary | 7 | 2024 | 1948 | 0.920 |
Why?
| | Respiratory System Abnormalities | 1 | 2025 | 18 | 0.910 |
Why?
| | Radiography, Abdominal | 1 | 2024 | 44 | 0.810 |
Why?
| | Photons | 5 | 2025 | 73 | 0.750 |
Why?
| | Bronchiolitis Obliterans | 2 | 2021 | 61 | 0.700 |
Why?
| | Lung | 11 | 2025 | 4089 | 0.680 |
Why?
| | Down Syndrome | 2 | 2025 | 522 | 0.670 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 45 | 0.660 |
Why?
| | Protein C | 1 | 2021 | 53 | 0.660 |
Why?
| | Child | 32 | 2026 | 22600 | 0.660 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 3 | 2025 | 122 | 0.630 |
Why?
| | Heart Defects, Congenital | 7 | 2025 | 905 | 0.610 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.590 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 10 | 0.590 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.590 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.590 |
Why?
| | Infant, Newborn | 14 | 2025 | 6399 | 0.570 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 26 | 0.560 |
Why?
| | Silicosis | 1 | 2018 | 30 | 0.550 |
Why?
| | Computed Tomography Angiography | 3 | 2025 | 146 | 0.540 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.540 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 93 | 0.530 |
Why?
| | Head | 1 | 2019 | 120 | 0.530 |
Why?
| | Child, Preschool | 17 | 2025 | 11790 | 0.510 |
Why?
| | Bronchiolitis | 1 | 2017 | 87 | 0.480 |
Why?
| | Infant | 20 | 2025 | 10023 | 0.480 |
Why?
| | Bronchiectasis | 3 | 2024 | 112 | 0.480 |
Why?
| | Spondylolysis | 1 | 2015 | 8 | 0.440 |
Why?
| | Marijuana Smoking | 1 | 2018 | 249 | 0.440 |
Why?
| | Imaging, Three-Dimensional | 2 | 2018 | 581 | 0.430 |
Why?
| | Humans | 57 | 2026 | 144667 | 0.420 |
Why?
| | Retrospective Studies | 23 | 2025 | 17149 | 0.410 |
Why?
| | Bone Cysts | 1 | 2013 | 11 | 0.380 |
Why?
| | Coronary Angiography | 2 | 2025 | 324 | 0.360 |
Why?
| | Male | 30 | 2026 | 72431 | 0.350 |
Why?
| | Biopsy | 4 | 2018 | 1079 | 0.340 |
Why?
| | Pediatrics | 1 | 2019 | 1121 | 0.320 |
Why?
| | Pulmonary Edema | 2 | 2022 | 105 | 0.320 |
Why?
| | Adolescent | 15 | 2026 | 22409 | 0.310 |
Why?
| | Coronary Vessels | 2 | 2022 | 246 | 0.300 |
Why?
| | Altitude Sickness | 2 | 2022 | 141 | 0.290 |
Why?
| | Female | 28 | 2026 | 78304 | 0.280 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 324 | 0.280 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2026 | 691 | 0.260 |
Why?
| | Mutation | 4 | 2024 | 4081 | 0.250 |
Why?
| | Brain | 1 | 2019 | 2934 | 0.240 |
Why?
| | Pulmonary Alveoli | 4 | 2021 | 383 | 0.240 |
Why?
| | Pulmonary Artery | 3 | 2024 | 1124 | 0.240 |
Why?
| | Reproducibility of Results | 4 | 2024 | 3414 | 0.230 |
Why?
| | Submandibular Gland | 1 | 2025 | 20 | 0.220 |
Why?
| | Radiography | 3 | 2018 | 848 | 0.220 |
Why?
| | Interleukin-5 | 1 | 2025 | 39 | 0.220 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 196 | 0.220 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 27 | 0.220 |
Why?
| | Lupus Nephritis | 1 | 2025 | 67 | 0.220 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 108 | 0.220 |
Why?
| | Body Size | 1 | 2024 | 94 | 0.200 |
Why?
| | Trachea | 3 | 2020 | 258 | 0.200 |
Why?
| | Signal-To-Noise Ratio | 2 | 2025 | 73 | 0.200 |
Why?
| | Tin | 1 | 2023 | 9 | 0.200 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 19 | 0.190 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 22 | 0.180 |
Why?
| | Abdominal Abscess | 1 | 2022 | 25 | 0.180 |
Why?
| | Sensitivity and Specificity | 2 | 2024 | 1995 | 0.180 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 51 | 0.180 |
Why?
| | Xeroderma Pigmentosum | 1 | 2022 | 9 | 0.180 |
Why?
| | Indoles | 1 | 2026 | 504 | 0.180 |
Why?
| | Coronary Circulation | 1 | 2022 | 134 | 0.180 |
Why?
| | Pulmonary Veins | 1 | 2023 | 104 | 0.180 |
Why?
| | Social Norms | 1 | 2022 | 31 | 0.170 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 990 | 0.170 |
Why?
| | Fractures, Bone | 2 | 2017 | 417 | 0.170 |
Why?
| | Bronchi | 2 | 2023 | 263 | 0.170 |
Why?
| | Sexism | 1 | 2022 | 69 | 0.170 |
Why?
| | Precision Medicine | 1 | 2025 | 454 | 0.170 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2021 | 37 | 0.170 |
Why?
| | Pleural Effusion | 1 | 2021 | 59 | 0.160 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 393 | 0.160 |
Why?
| | Esophageal Atresia | 1 | 2020 | 32 | 0.160 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 21 | 0.160 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.160 |
Why?
| | Vasculitis | 1 | 2021 | 69 | 0.160 |
Why?
| | Vaping | 1 | 2021 | 66 | 0.160 |
Why?
| | Surface-Active Agents | 1 | 2021 | 99 | 0.160 |
Why?
| | Tracheoesophageal Fistula | 1 | 2020 | 40 | 0.160 |
Why?
| | Joint Diseases | 1 | 2021 | 61 | 0.160 |
Why?
| | Mucolipidoses | 1 | 2020 | 9 | 0.160 |
Why?
| | Psoriasis | 1 | 2021 | 113 | 0.160 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 108 | 0.150 |
Why?
| | Protein Kinase Inhibitors | 1 | 2026 | 971 | 0.150 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 465 | 0.150 |
Why?
| | Fracture Healing | 2 | 2017 | 91 | 0.150 |
Why?
| | Renal Insufficiency | 1 | 2021 | 172 | 0.150 |
Why?
| | Hemorrhage | 2 | 2021 | 813 | 0.150 |
Why?
| | Death, Sudden | 1 | 2019 | 24 | 0.150 |
Why?
| | Echocardiography | 1 | 2022 | 644 | 0.140 |
Why?
| | Crohn Disease | 1 | 2022 | 259 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2021 | 677 | 0.140 |
Why?
| | Altitude | 2 | 2022 | 473 | 0.140 |
Why?
| | Lung Injury | 1 | 2021 | 236 | 0.140 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 253 | 0.140 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 33 | 0.140 |
Why?
| | Bronchioles | 1 | 2018 | 29 | 0.130 |
Why?
| | Respiration Disorders | 1 | 2018 | 78 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 252 | 0.130 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 410 | 0.130 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.130 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.130 |
Why?
| | Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.130 |
Why?
| | Bronchial Arteries | 1 | 2017 | 12 | 0.130 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1322 | 0.130 |
Why?
| | Airway Obstruction | 1 | 2019 | 153 | 0.130 |
Why?
| | Radiation Exposure | 1 | 2017 | 63 | 0.130 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2117 | 0.130 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3888 | 0.120 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 541 | 0.120 |
Why?
| | Bone Remodeling | 1 | 2017 | 71 | 0.120 |
Why?
| | Birth Injuries | 1 | 2016 | 18 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 217 | 0.120 |
Why?
| | Comorbidity | 2 | 2020 | 1652 | 0.120 |
Why?
| | Clavicle | 1 | 2016 | 38 | 0.120 |
Why?
| | Heart Rate | 1 | 2020 | 853 | 0.120 |
Why?
| | Young Adult | 5 | 2025 | 14122 | 0.120 |
Why?
| | Upper Extremity | 1 | 2017 | 113 | 0.110 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.110 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.110 |
Why?
| | Lumbosacral Region | 1 | 2015 | 59 | 0.110 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 312 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2022 | 850 | 0.110 |
Why?
| | Child Abuse | 2 | 2017 | 549 | 0.100 |
Why?
| | Wounds and Injuries | 1 | 2022 | 960 | 0.100 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 412 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1501 | 0.100 |
Why?
| | Humerus | 1 | 2013 | 39 | 0.090 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 252 | 0.090 |
Why?
| | Lower Extremity | 1 | 2017 | 440 | 0.090 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 5870 | 0.080 |
Why?
| | Femur | 1 | 2013 | 251 | 0.080 |
Why?
| | Postoperative Care | 1 | 2013 | 286 | 0.080 |
Why?
| | Hypoxia | 1 | 2017 | 1193 | 0.070 |
Why?
| | Bronchoscopy | 2 | 2020 | 227 | 0.070 |
Why?
| | Asthma | 1 | 2021 | 1774 | 0.070 |
Why?
| | Pandemics | 3 | 2022 | 1700 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2324 | 0.070 |
Why?
| | Adult | 4 | 2024 | 40489 | 0.060 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 12 | 0.060 |
Why?
| | Diarrhea | 1 | 2026 | 192 | 0.050 |
Why?
| | Prospective Studies | 3 | 2022 | 7994 | 0.050 |
Why?
| | Prognosis | 2 | 2024 | 4312 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 106 | 0.050 |
Why?
| | Fibrin | 1 | 2023 | 84 | 0.050 |
Why?
| | Cellulitis | 1 | 2022 | 53 | 0.050 |
Why?
| | Infliximab | 1 | 2022 | 111 | 0.040 |
Why?
| | False Positive Reactions | 1 | 2022 | 122 | 0.040 |
Why?
| | Necrosis | 1 | 2022 | 243 | 0.040 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2025 | 779 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 528 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 475 | 0.040 |
Why?
| | Treatment Outcome | 2 | 2026 | 11735 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 96 | 0.040 |
Why?
| | Face | 1 | 2022 | 174 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2003 | 961 | 0.040 |
Why?
| | Autoimmunity | 1 | 2025 | 930 | 0.040 |
Why?
| | Ultraviolet Rays | 1 | 2022 | 384 | 0.040 |
Why?
| | Ultrasonography | 1 | 2023 | 776 | 0.040 |
Why?
| | Heart | 1 | 2023 | 626 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 466 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 22 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2022 | 557 | 0.040 |
Why?
| | Infant, Premature | 1 | 2023 | 614 | 0.030 |
Why?
| | Eosinophils | 1 | 2021 | 316 | 0.030 |
Why?
| | Electric Impedance | 1 | 2018 | 110 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2019 | 305 | 0.030 |
Why?
| | Hyperplasia | 1 | 2018 | 177 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 115 | 0.030 |
Why?
| | Kidney | 1 | 2025 | 1495 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1207 | 0.030 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 22 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2017 | 54 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 1103 | 0.030 |
Why?
| | Bony Callus | 1 | 2016 | 6 | 0.030 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 58 | 0.030 |
Why?
| | Health Behavior | 1 | 2022 | 786 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 267 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 710 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2839 | 0.030 |
Why?
| | Observer Variation | 1 | 2016 | 355 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 480 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 980 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2892 | 0.020 |
Why?
| | Colorado | 1 | 2022 | 4558 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3147 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 2003 | 68 | 0.010 |
Why?
| | Peroxidase | 1 | 2003 | 167 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2003 | 315 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 376 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2003 | 630 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1363 | 0.010 |
Why?
| | Oxygen | 1 | 2003 | 984 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2521 | 0.010 |
Why?
| | Neutrophils | 1 | 2003 | 1118 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1505 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 4110 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5570 | 0.010 |
Why?
| | Animals | 1 | 2003 | 37948 | 0.000 |
Why?
|
|
Weinman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|